1 false false false false false false false false false false true false false false false false false No description of principal activity 2025-04-01 Sage Accounts Production Advanced 2025 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 04392523 2025-04-01 2026-03-31 04392523 2026-03-31 04392523 2025-03-31 04392523 2024-04-01 2025-03-31 04392523 2025-03-31 04392523 2024-03-31 04392523 bus:Director1 2025-04-01 2026-03-31 04392523 core:WithinOneYear 2026-03-31 04392523 core:WithinOneYear 2025-03-31 04392523 bus:Micro-entities 2025-04-01 2026-03-31 04392523 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 04392523 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 04392523 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 04392523 bus:FullAccounts 2025-04-01 2026-03-31
COMPANY REGISTRATION NUMBER: 04392523
Surgical Initiatives Limited
Filleted Unaudited Financial Statements
31 March 2026
Surgical Initiatives Limited
Statement of Financial Position
31 March 2026
2026
2025
£
£
Fixed assets
2,633
5,210
-------
-------
Current assets
313,154
373,624
Creditors: amounts falling due within one year
2,721
26,979
---------
---------
Net current assets
310,433
346,645
---------
---------
Total assets less current liabilities
313,066
351,855
Accruals and deferred income
1,941
1,885
---------
---------
311,125
349,970
---------
---------
Capital and reserves
311,125
349,970
---------
---------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2025: 1 ).
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 19 August 2026 , and are signed on behalf of the board by:
Dr H Grant
Director
Company registration number: 04392523
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 5 Minton Place, Victoria Road, Bicester, Oxon, OX26 6QB.